Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer
University of Pittsburgh
University of Pittsburgh
Eli Lilly and Company
University of Wisconsin, Madison
University of Wisconsin, Madison
M.D. Anderson Cancer Center
Washington University School of Medicine
Massachusetts General Hospital
Bayer
M.D. Anderson Cancer Center
Varian, a Siemens Healthineers Company
Brigham and Women's Hospital
Seagen Inc.
Boehringer Ingelheim
University of Arizona
M.D. Anderson Cancer Center
Stanford University
Sichuan Baili Pharmaceutical Co., Ltd.
Bristol-Myers Squibb
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eli Lilly and Company
Vanderbilt University Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Taichung Veterans General Hospital
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
All India Institute of Medical Sciences
Bayer
Mayo Clinic
Boehringer Ingelheim
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Providence Health & Services
Astellas Pharma Inc
National Institutes of Health Clinical Center (CC)
Janssen Pharmaceutical K.K.
National Cancer Institute (NCI)
National Taiwan University Hospital